Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Announces Plans for NCX 4251 Phase 2 Trial in Blepharitis

October 13, 2020

View Press Release Corporate presentation Contact us
Previous